The "2025 Drug Pricing" conference will delve into the latest trends in pharmaceutical pricing in Germany and across Europe, covering innovative drugs, generics, and biosimilars.
Key stakeholders, including representatives from the HTA body G-BA, pharmaceutical companies, statutory payers, and drug experts, will discuss the implementation of confidential pricing and the impact of the EU HTA regulation in Germany.
The conference is organised once a year in spring by Forum-Institut für Management.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
